02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
The Colorado Department of Labor and Employment (CDLE) has proposed amendments to its Wage Protectio...
Read More >
White & Case Technology Newsflash - In line with the increased protectionism around foreign direct ...
Read More >
As the Coronavirus (COVID-19) continues to disrupt travel and almost every other aspect of day-to-da...
Read More >
The City of St. Petersburg, Florida is one of the latest municipalities to incorporate the concepts ...
Read More >
Over the course of the past several years, several states have banned or severely restricted the abi...
Read More >
Not quite two years ago, the Supreme Court decided the case of Encino Motorcars, LLC v. Navarro, 138...
Read More >